Liminal BioSciences LMNL
$ 8.5
0.0%
Quarterly report 2022-Q2
added 08-10-2022
Country |
Canada |
IPO year |
- |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Mr. Kenneth Galbraith |
Employees in the company |
300 |
Shares |
30.2 M |
Market Cap[1] |
$ 256 M |
EBITDA (LTM) |
- |
P/E (LTM) |
-0.54 |
P/S (LTM) |
13.38 |
EPS (LTM) |
-10.38 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.